Biomedical Systems
Biomedical Systems Corporation was a U.S.–based provider of centralized clinical trial services and medical technology founded in 1975 by W. Raymond Barrett and headquartered in Maryland Heights, Missouri.[1] The company supplied cardiac safety, medical imaging and respiratory endpoint services, and supported electronic patient-reported outcomes (ePRO) for biopharmaceutical sponsors and CROs.[2] In April 2014 it sold its physician- and hospital-based cardiology testing unit to BioTelemetry for approximately $8.65 million in cash and stock,[3][4] and in September 2017 it was acquired by ERT (eResearch Technology).[5] Following ERT’s merger with Bioclinica, the parent company rebranded as Clario in 2021.[6] HistoryFounded in 1975, Biomedical Systems offered centralized cardiac safety, medical imaging and respiratory services in drug development and also collected, analyzed and distributed electronic patient-reported outcome (ePRO)[7] in multiple modalities across all phases of clinical research.[8] In 2010 Biomedical Systems introduced their own Wireless Ambulatory ECG Monitoring System called the TruVue™ Wireless Telemetry Device as part of their Cardiac Patient Services Business. TruVue would record and remotely transmit heartbeats for up to 30 days; and was intended for the diagnosis and management of atrial fibrillation and other cardiac arrhythmia.[9][independent source needed] Biomedical Systems later sold TruVue to Malvern, Pennsylvania-based BioTelemetry, Inc. for $8.65 million.[10] Later in 2012 Biomedical Systems added ePRO services through their acquisition of Belgium-based Symfo.[11] On September 8, 2017, ERT announced its acquisition of Biomedical Systems.[12] Controversies and legal issuesIn 2002, the U.S. Court of Appeals for the Eighth Circuit affirmed a jury verdict awarding Biomedical Systems $75 million in a breach-of-contract case against GE Marquette Medical Systems related to FDA clearance strategy for a home uterine activity monitor.[13] Locations
See alsoReferences
|
